Across TCGA pan-cancer cohorts, IFNA22P Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated IFNA22P data layer compared with 15 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher IFNA22P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated IFNA22P expression acts as an unfavorable survival marker.

COAD and SKCM are the cancer types where IFNA22P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.111	0.871	<.001	12	view →
SKCM	DFS	Median	All	0.063	0.757	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: IFNA22P tumor-vs-normal RNA expression · all IFNA22P data types